158 related articles for article (PubMed ID: 34933226)
1. Monte Carlo study of organ doses and related risk for cancer in Algeria from scattered neutrons in prostate treatment involving 3D-CRT.
Alem-Bezoubiri A; Suleiman SA; Behidj I; Mazrou H; Chami AC
Appl Radiat Isot; 2022 Feb; 180():110065. PubMed ID: 34933226
[TBL] [Abstract][Full Text] [Related]
2. Calculated organ doses from selected prostate treatment plans using Monte Carlo simulations and an anatomically realistic computational phantom.
Bednarz B; Hancox C; Xu XG
Phys Med Biol; 2009 Sep; 54(17):5271-86. PubMed ID: 19671968
[TBL] [Abstract][Full Text] [Related]
3. Out-of-field doses in pediatric craniospinal irradiations with 3D-CRT, VMAT, and scanning proton radiotherapy: A phantom study.
Majer M; Ambrožová I; Davídková M; De Saint-Hubert M; Kasabašić M; Knežević Ž; Kopeć R; Krzempek D; Krzempek K; Miljanić S; Mojżeszek N; Veršić I; Stolarczyk L; Harrison RM; Olko P
Med Phys; 2022 Apr; 49(4):2672-2683. PubMed ID: 35090187
[TBL] [Abstract][Full Text] [Related]
4. A comparative study on the risk of second primary cancers in out-of-field organs associated with radiotherapy of localized prostate carcinoma using Monte Carlo-based accelerator and patient models.
Bednarz B; Athar B; Xu XG
Med Phys; 2010 May; 37(5):1987-94. PubMed ID: 20527532
[TBL] [Abstract][Full Text] [Related]
5. Monte carlo study of organ doses and related risk for cancer in Tanzania from scattered photons in cervical radiation treatment involving Co-60 source.
Suleiman SA; Qi Y; Chen Z; Xu XG
Phys Med; 2019 Jun; 62():13-19. PubMed ID: 31153393
[TBL] [Abstract][Full Text] [Related]
6. Secondary cancer-incidence risk estimates for external radiotherapy and high-dose-rate brachytherapy in cervical cancer: phantom study.
Lee B; Ahn SH; Kim H; Son J; Sung J; Han Y; Huh SJ; Kim JS; Kim DW; Yoon M
J Appl Clin Med Phys; 2016 Sep; 17(5):124-132. PubMed ID: 27685104
[TBL] [Abstract][Full Text] [Related]
7. Assessment of organ-specific neutron equivalent doses in proton therapy using computational whole-body age-dependent voxel phantoms.
Zacharatou Jarlskog C; Lee C; Bolch WE; Xu XG; Paganetti H
Phys Med Biol; 2008 Feb; 53(3):693-717. PubMed ID: 18199910
[TBL] [Abstract][Full Text] [Related]
8. Peripheral photon and neutron doses from prostate cancer external beam irradiation.
Bezak E; Takam R; Marcu LG
Radiat Prot Dosimetry; 2015 Dec; 167(4):591-601. PubMed ID: 25564673
[TBL] [Abstract][Full Text] [Related]
9. MONTE CARLO SIMULATION OF OUT-OF-FIELD ORGAN DOSES AND CANCER RISK IN TANZANIA FOR RADIATION THERAPY OF UNILATERAL RETINOBLASTOMA USING A 60Co UNIT.
Suleiman SA; Qi Y; Pi Y; George Xu X
Radiat Prot Dosimetry; 2018 May; 179(3):263-270. PubMed ID: 29216393
[TBL] [Abstract][Full Text] [Related]
10. Monte Carlo study shows no significant difference in second cancer risk between 6- and 18-MV intensity-modulated radiation therapy.
Kry SF; Salehpour M; Titt U; White RA; Stovall M; Followill D
Radiother Oncol; 2009 Apr; 91(1):132-7. PubMed ID: 19147246
[TBL] [Abstract][Full Text] [Related]
11. Calculated organ doses using Monte Carlo simulations in a reference male phantom undergoing HDR brachytherapy applied to localized prostate carcinoma.
Candela-Juan C; Perez-Calatayud J; Ballester F; Rivard MJ
Med Phys; 2013 Mar; 40(3):033901. PubMed ID: 23464344
[TBL] [Abstract][Full Text] [Related]
12. Exposure of remote organs and associated cancer risks from tangential and multi-field breast cancer radiotherapy.
Simonetto C; Rennau H; Remmele J; Sebb S; Kundrát P; Eidemüller M; Wolf U; Hildebrandt G
Strahlenther Onkol; 2019 Jan; 195(1):32-42. PubMed ID: 30350118
[TBL] [Abstract][Full Text] [Related]
13. Monte Carlo study on the secondary cancer risk estimations for patients undergoing prostate radiotherapy: A humanoid phantom study.
Ghasemi-Jangjoo A; Ghiasi H
Rep Pract Oncol Radiother; 2020; 25(2):187-192. PubMed ID: 32021575
[TBL] [Abstract][Full Text] [Related]
14. Radiation dose and cancer risk to out-of-field and partially in-field organs from radiotherapy for symptomatic vertebral hemangiomas.
Mazonakis M; Tzedakis A; Lyraraki E; Damilakis J
Med Phys; 2016 Apr; 43(4):1841. PubMed ID: 27036581
[TBL] [Abstract][Full Text] [Related]
15. Photonuclear dose calculations for high-energy photon beams from Siemens and Varian linacs.
Chibani O; Ma CM
Med Phys; 2003 Aug; 30(8):1990-2000. PubMed ID: 12945965
[TBL] [Abstract][Full Text] [Related]
16. Equivalent dose and effective dose from stray radiation during passively scattered proton radiotherapy for prostate cancer.
Fontenot J; Taddei P; Zheng Y; Mirkovic D; Jordan T; Newhauser W
Phys Med Biol; 2008 Mar; 53(6):1677-88. PubMed ID: 18367796
[TBL] [Abstract][Full Text] [Related]
17. Validation of a Monte Carlo Framework for Out-of-Field Dose Calculations in Proton Therapy.
De Saint-Hubert M; Verbeek N; Bäumer C; Esser J; Wulff J; Nabha R; Van Hoey O; Dabin J; Stuckmann F; Vasi F; Radonic S; Boissonnat G; Schneider U; Rodriguez M; Timmermann B; Thierry-Chef I; Brualla L
Front Oncol; 2022; 12():882489. PubMed ID: 35756661
[TBL] [Abstract][Full Text] [Related]
18. Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy.
Murray LJ; Thompson CM; Lilley J; Cosgrove V; Franks K; Sebag-Montefiore D; Henry AM
Phys Med Biol; 2015 Feb; 60(3):1237-57. PubMed ID: 25590229
[TBL] [Abstract][Full Text] [Related]
19. The risk of second primary cancers due to peripheral photon and neutron doses received during prostate cancer external beam radiation therapy.
Bezak E; Takam R; Yeoh E; Marcu LG
Phys Med; 2017 Oct; 42():253-258. PubMed ID: 28302493
[TBL] [Abstract][Full Text] [Related]
20. Monte Carlo determination of radiation-induced cancer risks for prostate patients undergoing intensity- modulated radiation therapy.
Stathakis S; Li J; Ma CCM
J Appl Clin Med Phys; 2007 Sep; 8(4):14-27. PubMed ID: 18449157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]